IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway

Guodong Hu1, Betsy J Barnes2

  • 1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21231; New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103.

Insights

Interferon regulatory factor 5 (IRF-5) promotes tumor cell death by sensitizing them to TRAIL-induced apoptosis. This newly identified mediator enhances cell death signaling, particularly when combined with type I interferons.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Immunology

Background:

  • Cellular stress responses are regulated by genetic networks.
  • Interferon regulatory factor 5 (IRF-5) is involved in innate immunity and DNA damage-induced apoptosis.
  • Tumor suppressor p53 influences cell survival and death balance.

Purpose of the Study:

  • To investigate the role of IRF-5 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor (DR) signaling.
  • To elucidate the mechanism by which IRF-5 mediates apoptosis.

Main Methods:

  • Investigated IRF-5's role in TRAIL-induced apoptosis in tumor cells.
  • Assessed the impact of type I interferons on TRAIL-induced apoptosis in IRF-5 deficient cells.
  • Analyzed IRF-5's involvement in signaling pathways upstream of caspase 8 activation.
  • Examined TRAIL-induced phosphorylation and nuclear localization of IRF-5.

Main Results:

  • IRF-5 sensitizes tumor cells to TRAIL-induced apoptosis and cell death.
  • Type I interferons enhance TRAIL-induced cell death in an IRF-5-dependent manner.
  • Cells lacking IRF-5 show a diminished response to TRAIL and interferons.
  • IRF-5 acts upstream of caspase 8, increasing its activation.
  • TRAIL signaling leads to IRF-5 phosphorylation and nuclear translocation, activating DR signaling components.

Conclusions:

  • IRF-5 is a novel mediator of death receptor signaling.
  • IRF-5 plays a critical role in promoting apoptosis via the TRAIL pathway.
  • This study provides molecular insights into TRAIL-induced IRF-5 signaling in cancer cells.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.